Before we all get too excited, J&J isn't shedding the albatross that is William Weldon. Sadly, Billy-boy is still driving J&J into the ground. Rather, Johnson & Johnson announced today that the President of its embattled DePuy Orthopaedics group would be leaving the organization.
A replacement figurehead hasn't been named, but we can all be certain of two things: 1) it will be someone close to Weldon and 2) the person will have the same lack of focus on quality and patient safety as the rest of the Weldon's circle.
Like all the other J&J operating companies, DePuy had been plagued by product recalls and litigation problems. The company has amassed a $280 million reserve to cover expenses associated with a recall of its artificial hips earlier this year. That amount may be insufficient when you take into account the number of class action lawsuits alleging that the J&J delayed the recall and did not act decisively on specific warnings about problems (an altogether too familiar tune when it comes to J&J).